$TNXP
Tonix Pharmaceuticals Holding Corp.

2014 Q2 Form 10-Q Financial Statement

#000114420414030020 Filed on May 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.970M $1.620M $1.260M
YoY Change 72.81% 28.57% 65.79%
% of Gross Profit
Research & Development $4.075M $3.550M $741.0K
YoY Change 331.67% 379.08% 85.25%
% of Gross Profit
Depreciation & Amortization $10.00K $4.000K $4.000K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $6.049M $5.169M $2.001M
YoY Change 189.98% 158.32% 72.5%
Operating Profit -$6.049M -$5.169M
YoY Change 189.98%
Interest Expense $10.00K $10.00K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$6.040M -$5.160M -$2.000M
YoY Change 189.0% 158.0% -0.5%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.044M -$5.164M -$2.001M
YoY Change 189.74% 158.07% -0.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$604.0M -$516.0M -$918.0M
COMMON SHARES
Basic Shares Outstanding 9.929M shares 9.899M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.90M $49.50M $400.0K
YoY Change 43800.0% 12275.0% -84.0%
Cash & Equivalents $43.87M $49.50M $400.0K
Short-Term Investments
Other Short-Term Assets $900.0K $600.0K $100.0K
YoY Change 500.0% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $44.82M $50.10M $500.0K
YoY Change 39075.17% 9920.0% -80.77%
LONG-TERM ASSETS
Property, Plant & Equipment $71.00K $0.00 $0.00
YoY Change 82.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $249.0K $100.0K $100.0K
YoY Change 24.47% 0.0%
TOTAL ASSETS
Total Short-Term Assets $44.82M $50.10M $500.0K
Total Long-Term Assets $249.0K $100.0K $100.0K
Total Assets $45.07M $50.20M $600.0K
YoY Change 14231.78% 8266.67% -76.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.518M $1.400M $900.0K
YoY Change 3.88% 55.56% 350.0%
Accrued Expenses $573.0K $600.0K $300.0K
YoY Change -4.75% 100.0% 200.0%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $300.0K $0.00
YoY Change 50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.371M $2.300M $1.200M
YoY Change 4.78% 91.67% 300.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.371M $2.300M $1.200M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.401M $2.300M $1.200M
YoY Change 5.4% 91.67% -60.0%
SHAREHOLDERS EQUITY
Retained Earnings -$37.94M
YoY Change
Common Stock $80.60M
YoY Change 348.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.66M $47.92M -$600.0K
YoY Change
Total Liabilities & Shareholders Equity $45.07M $50.20M $600.0K
YoY Change 14231.78% 8267.33% -76.92%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$6.044M -$5.164M -$2.001M
YoY Change 189.74% 158.07% -0.45%
Depreciation, Depletion And Amortization $10.00K $4.000K $4.000K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$5.700M -$4.060M -$1.360M
YoY Change 650.0% 198.53% -23.6%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $2.000K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$70.00K $0.00 $0.00
YoY Change
Cash From Investing Activities -$110.0K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $40.65M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 130.0K 45.41M 0.000
YoY Change -68.29% -100.0%
NET CHANGE
Cash From Operating Activities -5.700M -4.060M -1.360M
Cash From Investing Activities -110.0K 0.000 0.000
Cash From Financing Activities 130.0K 45.41M 0.000
Net Change In Cash -5.680M 41.35M -1.360M
YoY Change 1522.86% -3140.44% -155.28%
FREE CASH FLOW
Cash From Operating Activities -$5.700M -$4.060M -$1.360M
Capital Expenditures -$40.00K $2.000K $0.00
Free Cash Flow -$5.660M -$4.062M -$1.360M
YoY Change 644.74% 198.68% -23.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
280000 USD
CY2013Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
280000 USD
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001430306
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6512000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8736000 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
31892000 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
26728000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
47923000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50204000 USD
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
72000 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
46000 USD
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
491000 USD
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9902379 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5823081 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9902379 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5823081 shares
CY2013Q4 tnxp Common Stock Shares To Be Issued
CommonStockSharesToBeIssued
11002 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2001000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5162000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31891000 USD
CY2014Q1 tnxp Working Capital Amount
WorkingCapitalAmount
48000000 USD
CY2014Q1 tnxp Proceeds From Issuance Secondary Public Offering
ProceedsFromIssuanceSecondaryPublicOffering
40700000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4800000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
741000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3550000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12735000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1260000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1619000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16191000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2001000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
5169000 USD
us-gaap Operating Expenses
OperatingExpenses
28926000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-28926000 USD
CY2013Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2013Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1799000 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2006160 shares
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
187438 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2001000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-5164000 USD
us-gaap Net Income Loss
NetIncomeLoss
-31892000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2159130 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8718199 shares
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
269844 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
98758 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
553000 USD
CY2014Q1 tnxp Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4758000 USD
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40654000 USD
CY2013 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
62500 USD
CY2014Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
37723 USD
CY2013Q1 us-gaap Depreciation
Depreciation
4000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
4000 USD
us-gaap Depreciation
Depreciation
53000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
250000 USD
CY2013Q1 tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
0 USD
CY2014Q1 tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
0 USD
tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
710000 USD
CY2013Q1 tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
0 USD
CY2014Q1 tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
426000 USD
CY2013Q1 tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
0 USD
CY2014Q1 tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
81000 USD
CY2013Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
11000 USD
CY2014Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
51000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
392000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
553000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3822000 USD
CY2013Q1 tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
CY2014Q1 tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
608000 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
991000 USD
CY2013Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-156000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
126000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
555000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
635000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1401000 USD
CY2013Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3000 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3000 USD
CY2013Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
36000 USD
CY2014Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-572000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
688000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
44000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-1000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-2000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
17000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1362000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4064000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22785000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96000 USD
CY2013Q1 tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
0 USD
CY2014Q1 tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
0 USD
tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
60000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-156000 USD
CY2013Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
CY2014Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
480000 USD
CY2013Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2014Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1020000 USD
CY2013Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2014Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
280000 USD
CY2013Q1 tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
0 USD
CY2014Q1 tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
4758000 USD
tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
9386000 USD
CY2013Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2014Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1891000 USD
CY2013Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2014Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
40654000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42608000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
45412000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
72490000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
0 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-1000 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-2000 USD
CY2013Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1362000 USD
CY2014Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
41345000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
49547000 USD
CY2012Q4 us-gaap Cash
Cash
1786000 USD
CY2007Q2 us-gaap Cash
Cash
0 USD
CY2013Q1 us-gaap Cash
Cash
424000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
3000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
38000 USD
CY2013Q1 tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
CY2014Q1 tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
200000 USD
CY2013Q1 tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
CY2014Q1 tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
27000 USD
CY2013Q1 tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
CY2014Q1 tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
549000 USD
CY2013Q1 tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
CY2014Q1 tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
144000 USD
CY2013Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
CY2014Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
820000 USD
CY2013Q1 tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
0 USD
CY2014Q1 tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
0 USD
tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
3939000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2014Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2635000 USD
CY2011 us-gaap Debt Issuance Costs
DebtIssuanceCosts
24000 USD
CY2013Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
CY2014Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
16975000 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in accordance with&#160;accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the useful life of fixed assets, assumptions used in the fair value of stock-based compensation and other equity instruments, and the percent of completion of research and development contracts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
277509 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
285404 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
293537 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
TNXP
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9929206 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
Tonix Pharmaceuticals Holding Corp.
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 tnxp Stock Issued During Period Value Intellectual Property Acquired
StockIssuedDuringPeriodValueIntellectualPropertyAcquired
608000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0202 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0219 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9996 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0073 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
392323 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
552601 USD
CY2012 tnxp Payments Of Stock Issuance Costs1
PaymentsOfStockIssuanceCosts1
506000 USD
CY2013 tnxp Payments Of Stock Issuance Costs1
PaymentsOfStockIssuanceCosts1
1352000 USD
CY2014Q1 tnxp Payments Of Stock Issuance Costs1
PaymentsOfStockIssuanceCosts1
USD
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
72354 USD
CY2014Q1 us-gaap Other Commitment
OtherCommitment
8000000 USD
CY2014Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
132417 USD

Files In Submission

Name View Source Status
0001144204-14-030020-index-headers.html Edgar Link pending
0001144204-14-030020-index.html Edgar Link pending
0001144204-14-030020.txt Edgar Link pending
0001144204-14-030020-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tnxp-20140331.xml Edgar Link completed
tnxp-20140331.xsd Edgar Link pending
tnxp-20140331_cal.xml Edgar Link unprocessable
tnxp-20140331_def.xml Edgar Link unprocessable
tnxp-20140331_lab.xml Edgar Link unprocessable
tnxp-20140331_pre.xml Edgar Link unprocessable
v377242_10q.htm Edgar Link pending
v377242_ex31-01.htm Edgar Link pending
v377242_ex31-02.htm Edgar Link pending
v377242_ex32-01.htm Edgar Link pending